Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Beatriz Collado"'
Publikováno v:
Regulatory Peptides. 144:101-108
Previous studies have shown that vasoactive intestinal peptide (VIP) and its receptors (VPAC(1) and VPAC(2) receptors) are involved in promotion and growth of many human tumours including breast cancer. Here we investigated whether VIP regulates the
Publikováno v:
Molecular and Cellular Endocrinology. 249:116-122
Vascular endothelial growth factor (VEGF) is a main factor promoting neovascularization (angiogenesis) of solid tumours as prostate carcinoma. Hypoxia stimulates VEGF gene expression by activating the hypoxia-inducible factor-1 (HIF-1alpha). In the p
Autor:
Juan C. Prieto, Nuria Olea, Beatriz Collado, María J. Carmena, Sophie Malagarie-Cazenave, María G. Sánchez, Ana Maria Sanchez, Inés Díaz-Laviada
Publikováno v:
European Journal of Pharmacology. 515:20-27
Vanilloid receptor subtype-1 (TRPV1), the founding member of the vanilloid receptor-like transient receptor potential channel family, is a non-selective cation channel that responds to noxious stimuli such as low pH, painful heat and irritants. In th
Autor:
Beatriz Collado, Nieves Rodríguez-Henche, María J. Carmena, Maria G. Juarranz, Irene Gutiérrez-Cañas, Juan C. Prieto, Antonio Chiloeches
Publikováno v:
The Prostate. 63:44-55
BACKGROUND. Neuroendocrine (NE) differentiation in prostate cancer has been correlated with unfavorable clinical outcome. The mechanisms by which prostate cancer acquires NE properties are poorly understood, but several signaling pathways have been p
Publikováno v:
Peptides. 28(9)
We show that vasoactive intestinal peptide (VIP) exerts trophic and proangiogenic activities in experimental prostate cancer in vivo . Nude mice were subcutaneously injected with Matrigel impregnated with LNCaP prostate cancer cells. Cell treatment w
Autor:
Ana B, Fernández-Martínez, Beatriz, Collado, Ana M, Bajo, Manuel, Sánchez-Chapado, Juan C, Prieto, María J, Carmena
Publikováno v:
Molecular and cellular endocrinology. 270(1-2)
The effect of vasoactive intestinal peptide (VIP) on cyclooxygenase-2 (COX-2) expression was analyzed in human prostate non-neoplastic (RWPE-1) as well as cancer androgen-dependent (LNCaP) and independent (PC3) cells. The three cell lines expressed V
Autor:
Antonio Ruı́z-Villaespesa, J Cortés, Guillermo Bodega, Juan C. Prieto, María J. Carmena, Molga García-Fernández, Beatriz Collado
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 20(6)
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) bind similarly to VPAC1 and VPAC2 receptors, whereas PACAP binds with higher affinity than VIP to PAC1 receptors. Here we demonstrate by different approach
Autor:
Irene, Gutiérrez-Cañas, María G, Juarranz, Beatriz, Collado, Nieves, Rodríguez-Henche, Antonio, Chiloeches, Juan C, Prieto, María J, Carmena
Publikováno v:
The Prostate. 63(1)
Neuroendocrine (NE) differentiation in prostate cancer has been correlated with unfavorable clinical outcome. The mechanisms by which prostate cancer acquires NE properties are poorly understood, but several signaling pathways have been proposed. We
Publikováno v:
International Journal of Oncology.
The mechanisms by which luteinizing hormone-releasing hormone (LH-RH) antagonists act on extra-pituitary tissues are poorly understood. In view of extensive use of Cetrorelix in gynecology and oncology, we investigated its effects on signal transduct
Publikováno v:
International journal of oncology. 24(3)
The mechanisms by which luteinizing hormone-releasing hormone (LH-RH) antagonists act on extra-pituitary tissues are poorly understood. In view of extensive use of Cetrorelix in gynecology and oncology, we investigated its effects on signal transduct